Erythropoietin ameliorates chemotherapy-induced toxicity in...

Details Erythropoietin ameliorates chemotherapy-induced toxicity in... Erythropoietin ameliorates chemotherapy-induced toxicity in...

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61K 31/7064 (2006.01) A61K 38/20 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2443025

A method of reducing organ toxicity in a subject being administered a cytotoxic agent comprising concurrently administering with the cytotoxic agent erythropoietin (EPO), the EPO being administered in an amount effective to reduce pulmonary toxicity caused by the cytotoxic agent.

L'invention concerne une méthode permettant de réduire la toxicité organique chez un sujet à qui on administre un agent cytotoxique, laquelle méthode consiste à administrer parallèlement l'agent cytotoxique érythropoïétine (EPO), l'EPO étant administré en quantité efficace pour permettre la réduction de la toxicité pulmonaire causée par l'agent cytotoxique.

Affiliated with

Also associated with

Rating

Erythropoietin ameliorates chemotherapy-induced toxicity in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythropoietin ameliorates chemotherapy-induced toxicity in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin ameliorates chemotherapy-induced toxicity in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2046337